Impact of advanced Parkinson’s disease on caregivers: an international real-world study

por Martinez-Martin, Pablo, Skorvanek, Matej, Henriksen, Tove, Lindvall, Susanna, Domingos, Josefa, Alobaidi, Ali, Kandukuri, Prasanna L., Chaudhari, Vivek S., Patel, Apeksha B., Parra, Juan Carlos, Pike, James, Antonini, Angelo
Publicado 2023

Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries

por Malaty, Irene A., Martinez-Martin, Pablo, Chaudhuri, K. Ray, Odin, Per, Skorvanek, Matej, Jimenez-Shahed, Joohi, Soileau, Michael J., Lindvall, Susanna, Domingos, Josefa, Jones, Sarah, Alobaidi, Ali, Jalundhwala, Yash J., Kandukuri, Prasanna L., Onuk, Koray, Bergmann, Lars, Femia, Samira, Lee, Michelle Y., Wright, Jack, Antonini, Angelo
Publicado 2022

Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries

por Antonini, Angelo, Pahwa, Rajesh, Odin, Per, Henriksen, Tove, Soileau, Michael J., Rodriguez-Cruz, Ramon, Isaacson, Stuart H., Merola, Aristide, Lindvall, Susanna, Domingos, Josefa, Alobaidi, Ali, Jalundhwala, Yash J., Kandukuri, Prasanna L., Parra, Juan Carlos, Kukreja, Pavnit K., Onuk, Koray, Bergmann, Lars, Pike, James, Ray Chaudhuri, K.
Publicado 2022